FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maximilian Lobmeyer

Research Profile

Genes & Molecular Sequences

Physiology

Occupations

Pharmacogenetics

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
MyPhuong T Le; Maximilian T Lobmeyer; Stephen T Turner; Zhiying Wang; Eric Boerwinkle; Marcus Campbell; Arlene B Chapman; Jing Cheng; Yan Gong; John G Gums; Richard J Johnson; Julie A Johnson
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals.
Alexander G Vandell; Taimour Y Langaee; Stephen B Liggett; Maximilian T Lobmeyer; Carl J Pepine; Stephen T Turner; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Brian E Gawronski; Yan Gong; John G Gums; Julie A Johnson
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Yan Gong; Amber L Beitelshees; Rhonda M Cooper-DeHoff; Maximilian T Lobmeyer; Taimour Y Langaee; Jun Wu; Sharon Cresci; Michael A Province; John A Spertus; Carl J Pepine; Julie A Johnson
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maximilian Lobmeyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: MyPhuong T Le; Maximilian T Lobmeyer; Stephen T Turner; Zhiying Wang; Eric Boerwinkle; Marcus Campbell; Arlene B Chapman; Jing Cheng; Yan Gong; John G Gums; Richard J Johnson; Julie A Johnson
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals.
PloS one 2013;8(1):e52062.
2012: Alexander G Vandell; Taimour Y Langaee; Stephen B Liggett; Maximilian T Lobmeyer; Carl J Pepine; Stephen T Turner; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Brian E Gawronski; Yan Gong; John G Gums; Julie A Johnson
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Hypertension 2012;60(4):957-64.
2011: Yan Gong; Amber L Beitelshees; Rhonda M Cooper-DeHoff; Maximilian T Lobmeyer; Taimour Y Langaee; Jun Wu; Sharon Cresci; Michael A Province; John A Spertus; Carl J Pepine; Julie A Johnson
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.
Circulation. Cardiovascular genetics 2011;4(2):169-78.
2011: Maximilian T Lobmeyer; Liewei Wang; Issam Zineh; Stephen T Turner; John G Gums; Arlene B Chapman; Rhonda M Cooper-DeHoff; Amber L Beitelshees; Kent R Bailey; Eric Boerwinkle; Carl J Pepine; Julie A Johnson
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
Pharmacogenetics and genomics 2011;21(1):42-9.
2010: Julio Duarte; Maximilian T Lobmeyer; Zhiying Wang; Arlene B Chapman; John G Gums; Taimour Y Langaee; Eric Boerwinkle; Stephen T Turner; Julie A Johnson
Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazide.
Pharmacogenetics and genomics 2010;20(8):516-9.
2008: Stephan Schmidt; Katharina Röck; Martina Sahre; Olaf Burkhardt; Martin Brunner; Maximilian T Lobmeyer; Hartmut Derendorf
Effect of protein binding on the pharmacological activity of highly bound antibiotics.
Antimicrobial agents and chemotherapy 2008;52(11):3994-4000.
2008: Tobias Gerhard; Yan Gong; Amber L Beitelshees; Xianyun Mao; Maximilian T Lobmeyer; Rhonda M Cooper-DeHoff; Taimour Y Langaee; Nicholas J Schork; Mark D Shriver; Carl J Pepine; Julie A Johnson
Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
American heart journal 2008;156(2):397-404.
2007: Maximilian T Lobmeyer; Yan Gong; Steven G Terra; Amber L Beitelshees; Taimour Y Langaee; Daniel F Pauly; Richard S Schofield; Karen K Hamilton; J Herbert Patterson; Kirkwood F Adams; James A Hill; Juan M Aranda; Julie A Johnson
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Pharmacogenetics and genomics 2007;17(4):277-82.
2007: Jaekyu Shin; Maximilian T Lobmeyer; Yan Gong; Issam Zineh; Taimour Y Langaee; Hossein Najaf Yarandi; Richard S Schofield; Juan M Aranda; James A Hill; Daniel F Pauly; Julie A Johnson
Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure.
The American journal of cardiology 2007;99(2):250-5.
2004: Christina L Aquilante; Maximilian T Lobmeyer; Taimour Y Langaee; Julie A Johnson
Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory.
Pharmacotherapy 2004;24(6):720-6.